Examinando por Autor "Louphrasitthiphol, P"
Mostrando 1 - 1 de 1
- Resultados por página
- Opciones de ordenación
Ítem Lineage-restricted regulation of SCD and fatty acid saturation by MITF controls melanoma phenotypic plasticity.(Mol Cell, 2020-01-02) Vivas-García, Yurena; Falletta, P; Liebing, J; Louphrasitthiphol, P; Feng, Y; Chauhan, J; Scott, DA; Glodde, N; Chocarro-Calvo, A; Bonham, S; Osterman, A; Fischer, R; Ronai, Z; García-Jiménez, C; Hölzel, M; Goding, CRPhenotypic and metabolic heterogeneity within tumors is a major barrier to effective cancer therapy. How metabolism is implicated in specific phenotypes and whether lineage-restricted mechanisms control key metabolic vulnerabilities remain poorly understood. In melanoma, downregulation of the lineage addiction oncogene microphthalmia-associated transcription factor (MITF) is a hallmark of the proliferative-to-invasive phenotype switch, although how MITF promotes proliferation and suppresses invasion is poorly defined. Here, we show that MITF is a lineage-restricted activator of the key lipogenic enzyme stearoyl-CoA desaturase (SCD) and that SCD is required for MITFHigh melanoma cell proliferation. By contrast MITFLow cells are insensitive to SCD inhibition. Significantly, the MITF-SCD axis suppresses metastasis, inflammatory signaling, and an ATF4-mediated feedback loop that maintains de-differentiation. Our results reveal that MITF is a lineage-specific regulator of metabolic reprogramming, whereby fatty acid composition is a driver of melanoma phenotype switching, and highlight that cell phenotype dictates the response to drugs targeting lipid metabolism.